ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV) presented data demonstrating the synergistic antiviral activity from the combination of its two investigational drugs ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE